Ranbaxy Laboratories Ltd. v. Addl. CIT

39 SOT 17Income Tax Appellate Tribunal2010#4866 most cited

What is Ranbaxy Laboratories Ltd. v. Addl. CIT authority for?

Expenditure incurred for bringing goodwill to the assessee or for promoting the business is allowable as a deduction.

24

judgments rely on this decision, according to BharatTax’s citation analysis of 292,668 Indian tax judgments — from 2015 to 2025.

Also referred to as

Ranbaxy Laboratories Ltd. v. Addl. CIT · 39 SOT 17 · ITAT 2010 · CSR expenditure · goodwill expenditure · business promotion expenditure · allowable expenditure · section 37(1) · Income Tax Act

Issues it is cited on

Judgments citing Ranbaxy Laboratories Ltd. v. Addl. CIT

AMEE FOSTER WHEELER INDIA PVT. LTD.,,CHENNAI vs. ACIT, CORPORATE RANGE-1,, CHENNAI

In the result, the appeal filed by the assessee is partly allowed for statistical purposes

ITA 680/CHNY/2020[2014-15]Status: DisposedITAT Chennai22 Dec 2022AY 2014-15

Bench: Shri Mahavir Singhand Shri Manoj Kumar Aggarwalआयकर अपील सं./Ita No.: 680/Chny/2020 िनधा"रण वष"/Assessment Year: 2014-15 Amec Foster Wheeler India Pvt. The Acit (Osd), Ltd., Vs. Corporate Range -1, Zenith Building, 6Th Floor, Chennai Ascendas It Park, Csir Road, Taramani, Chennai – 600 113. Pan : Aaacf 3204C (अपीलाथ"/Appellant) (""यथ"/Respondent) अपीलाथ" क" ओर से/Appellant By : Ms. K.Amulya, Ca & Ms. V. Rajeswari, Ca ""यथ" क" ओर से/Respondent By : Shri S. Marudhu Pandyan, Cit सुनवाई क" तार"ख/Date Of Hearing : 22.12.2022 घोषणा क" तार"ख/Date Of Pronouncement : 22.12.2022 आदेश /O R D E R Per Mahavir Singh: This Appeal By Assessee Is Arising Out Of The Order Of The Commissioner Of Income Tax (Appeals)-4, Chennai In Ita No.479/16-17/Cit(A)-4/A.Y.2014-15 Dated 06.02.2020. The Assessment Was Framed By The Acit(Osd), Corporate Range-1, Chennai For The Assessment Year 2014-15, U/S.143(3) Of The Income Tax Act, 1961 (Hereinafter The ‘Act’), Vide Order Dated 29.12.2016. 2. The First Issue In This Appeal Of Assessee Is As Regards To The Order Of Cit(A) Confirming The Action Of Ao In Making Disallowance Of Cost Incurred In Connection With Off The Shelf Software Products Treating The Same As Royalty Under The Provisions Of The Act Read With Relevant Treaties. For This, Assessee Raised Ground Nos. 2 To 4 But The Relevant Ground Is Ground No.2, Which Reads As Under:- “2. The Ld. Cit(A) & Ld. Ao Erred In Non-Consideration Of The Fact That The Said Expenditure Merely Represents Cost To Cost Reimbursement Of Expenditure Incurred On Behalf Of The Appellant By Afwg Overseas Entities & Therefore, No Income Arises In The Hands Of Afwg Entities Necessitating The Obligation To Withhold Taxes On The Part Of The Appellant Under The Provisions Of The Act.”

For Appellant: Ms. K.Amulya, CA &For Respondent: Shri S. Marudhu Pandyan, CIT
Section 143(3)Section 40Section 9(1)(vi)Section 9(1)(vii)

…as incurred expenses by way of payment to its parent company which has in turn issued shares to the employees of the assessee and therefore, as considered by the AO, the decision of Delhi Tribunal in the case of Ranbaxy Laboratories Ltd., vs. Addl.CIT, [2010] 39 SOT 17, wherein ESOP expenditure is purely held to be notional. The ld.AR stated that the assessee has incurred expenses towards disbursing compensation to the employees for their services and hence, the same is revenue in nature. For this, she relied on the decision of Chennai Tribunal in the case of Caterpillar India (P) Ltd., vs. DCIT in ITA No.1722/Ch…

Showing 120 of 24 · Page 1 of 2

Ranbaxy Laboratories Ltd. v. Addl. CIT (39 SOT 17) — Cited in 24 Judgments | BharatTax